Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 5.30%203.62B | 11.73%219.03B | 3.90%192.18B | 3.25%780.94B | 1.64%206.56B | -0.89%193.38B | 2.91%196.03B | 10.39%184.97B | 20.18%756.38B | 19.40%203.23B |
Cost of revenue | -1.56%129.47B | 15.72%157.58B | -3.82%120.22B | 5.10%540.96B | 2.07%148.27B | 7.69%131.52B | -0.24%136.18B | 12.79%124.99B | 21.04%514.71B | 25.07%145.26B |
Gross profit | 19.87%74.15B | 2.66%61.45B | 20.00%71.97B | -0.70%239.98B | 0.56%58.29B | -15.24%61.86B | 10.90%59.86B | 5.70%59.97B | 18.38%241.66B | 7.21%57.97B |
Operating expense | 11.10%45.69B | 11.36%44.78B | 11.71%43.17B | 6.46%164.51B | 6.83%44.52B | 2.24%41.13B | 5.73%40.21B | 11.73%38.65B | 17.17%154.52B | 15.34%41.68B |
Selling and administrative expenses | 11.10%45.69B | 11.36%44.78B | 11.71%43.17B | 6.46%164.51B | 6.83%44.52B | 2.24%41.13B | 5.73%40.21B | 11.73%38.65B | 17.17%154.52B | 15.34%41.68B |
-Selling and marketing expense | 16.19%11.62B | 11.38%11.46B | 7.24%11.21B | -9.73%42.14B | -6.92%11.4B | -18.63%10B | -14.78%10.29B | 3.78%10.45B | 20.55%46.68B | 13.65%12.24B |
-General and administrative expense | 9.47%34.07B | 11.36%33.32B | 13.36%31.97B | 13.47%122.37B | 12.55%33.13B | 11.42%31.13B | 15.28%29.92B | 14.99%28.2B | 15.77%107.85B | 16.06%29.43B |
Operating profit | 37.27%28.46B | -15.14%16.67B | 35.02%28.8B | -13.39%75.48B | -15.47%13.77B | -36.71%20.73B | 23.21%19.65B | -3.70%21.33B | 20.60%87.14B | -9.18%16.29B |
Net non-operating interest income (expenses) | 565.57%284M | 89.15%-46M | 247.12%459M | 3.28%-974M | -22.07%-177M | 76.08%-61M | -41.81%-424M | -1.30%-312M | 32.23%-1.01B | 64.55%-145M |
Non-operating interest income | 62.01%951M | 72.30%653M | 343.40%1.18B | 309.11%1.84B | 144.98%610M | 582.56%587M | 511.29%379M | 400.00%265M | 219.15%450M | 336.84%249M |
Non-operating interest expense | 2.93%667M | -12.95%699M | 24.09%716M | 93.21%2.82B | 99.75%787M | 90.03%648M | 122.44%803M | 59.83%577M | -10.45%1.46B | -15.45%394M |
Net investment income | 111.80%168M | -15.28%255M | 64.41%97M | -496.74%-1.83B | -10.50%-768M | -2,194.12%-1.42B | 34.38%301M | -38.54%59M | -184.11%-307M | -2,880.00%-695M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -92.74%9M | -65.91%891M | -12.50%91M | -50.40%124M | 307.17%2.61B | -2.80%104M | ||||
Income from associates and other participating interests | 115.38%56M | 22.45%60M | 102.13%95M | -26.20%200M | 27.87%78M | -61.76%26M | -39.51%49M | -22.95%47M | 3.83%271M | -15.28%61M |
Special income (charges) | -199.73%-2.61B | -515.70%-3.81B | 96.54%-251M | 0.39%-8.64B | -38.94%-3.39B | 458.08%2.61B | 73.90%-618M | -130.84%-7.25B | 22.99%-8.68B | 32.47%-2.44B |
Less:Other special charges | 111.32%296M | 515.70%3.81B | -96.54%251M | -41.68%4.25B | -195.44%-1B | -458.08%-2.61B | -73.90%618M | 130.84%7.25B | -24.82%7.29B | -48.43%1.05B |
Less:Write off | ---- | ---- | ---- | 216.97%4.39B | ---- | ---- | ---- | ---- | -11.73%1.39B | ---- |
Other non-operating income (expenses) | -4,547.37%-2.65B | 45.37%-778M | -117.12%-1.59B | -88.80%-3.84B | -6.66%-1.63B | 87.50%-57M | -308.02%-1.42B | -343.33%-730M | 1.74%-2.04B | -319.66%-1.53B |
Income before tax | 8.05%23.72B | -23.82%13.87B | 110.19%27.61B | -21.44%61.27B | -31.54%7.98B | -30.75%21.96B | 17.51%18.21B | -31.41%13.14B | 32.88%78B | -21.40%11.65B |
Income tax | 6.26%7.63B | 19.71%5.48B | 16.17%5.49B | -15.19%18.99B | -40.99%2.51B | -14.57%7.18B | 21.64%4.58B | -20.88%4.73B | 10.08%22.39B | -28.91%4.25B |
Net income | 8.91%16.09B | -38.42%8.39B | 163.02%22.12B | -23.96%42.29B | -26.10%5.47B | -36.58%14.78B | 16.19%13.63B | -36.19%8.41B | 44.96%55.61B | -16.33%7.4B |
Net income continuous operations | 8.92%16.1B | -38.43%8.39B | 163.02%22.12B | -23.96%42.29B | -26.10%5.47B | -36.58%14.78B | 16.19%13.63B | -36.19%8.41B | 44.97%55.61B | -16.31%7.4B |
Noncontrolling interests | -168.66%-92M | -642.37%-438M | 96.50%505M | -112.31%-160M | -287.07%-492M | -59.76%134M | -126.11%-59M | -46.23%257M | 18.40%1.3B | 45.30%263M |
Net income attributable to the company | 10.54%16.19B | -35.49%8.83B | 165.14%21.61B | -21.84%42.45B | -16.46%5.96B | -36.23%14.65B | 18.98%13.69B | -35.82%8.15B | 45.74%54.31B | -17.63%7.13B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 10.54%16.19B | -35.49%8.83B | 165.14%21.61B | -21.84%42.45B | -16.46%5.96B | -36.23%14.65B | 18.98%13.69B | -35.82%8.15B | 45.74%54.31B | -17.63%7.13B |
Gross dividend payment | ||||||||||
Basic earnings per share | 13.47%49.63 | -34.87%26.64 | 165.02%64.56 | -21.31%126.8 | -17.17%17.8 | -35.98%43.74 | 19.56%40.9 | -34.36%24.36 | 48.75%161.13 | -14.62%21.49 |
Diluted earnings per share | 13.45%49.59 | -34.87%26.62 | 165.08%64.52 | -21.30%126.71 | -17.14%17.79 | -35.97%43.71 | 19.57%40.87 | -34.36%24.34 | 48.76%161 | -14.63%21.47 |
Dividend per share | 0 | 8.00%27 | 0 | 13.64%50 | 8.70%25 | 0 | 19.05%25 | 0 | 10.00%44 | 15.00%23 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |